<?xml version="1.0" encoding="UTF-8"?>
<fig fig-type="Figure" xml:lang="en" id="emmm201910938-fig-0005" orientation="portrait" position="float">
 <label>Figure 5</label>
 <caption>
  <title>
   <styled-content style="fixed-case" toggle="no">AAV</styled-content>‐
   <styled-content style="fixed-case" toggle="no">HA</styled-content>,
   <styled-content style="fixed-case" toggle="no"> AAV</styled-content>‐
   <styled-content style="fixed-case" toggle="no">NP</styled-content>, and 
   <styled-content style="fixed-case" toggle="no">AAV</styled-content>‐
   <styled-content style="fixed-case" toggle="no">cHA</styled-content> induce broad protection against H1N1 challenge
  </title>
  <p>
   <list list-type="simple" id="emmm201910938-list-0006">
    <list-item>
     <label>A–F</label>
     <p>Mice were vaccinated three times with AAV vectors or two times with WIV and then challenged with a lethal dose of homologous influenza virus (Cal/7/9) (A, B; 
      <italic>n</italic> = 5) or two different lethal doses of the heterologous PR8 strain (C, D; 
      <italic>n</italic> = 6 and E, F; 
      <italic>n</italic> = 7). Survival was monitored over a 14‐day period and is depicted as Kaplan–Meier plot (A, C, E). Weight loss was determined during the 14‐day period, which is shown in relation to the weight at day 0 (B, D, F). Mean ± SE. Statistical significance between negative control group (AAV‐GFP) or WIV group (E), and each vaccine group was determined using log‐rank (Mantel–Cox) test (*
      <italic>P</italic> &lt; 0.05, **
      <italic>P</italic> &lt; 0.01).
     </p>
    </list-item>
   </list>
  </p>
 </caption>
 <graphic id="nlm-graphic-19" xlink:href="EMMM-12-e10938-g010" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</fig>
